☰

Brian Wigdahl - Publications

Affiliations: 
Pennsylvania State University, State College, PA, United States 
Area:
Molecular Biology, Microbiology Biology
Tree Info Similar researchers PubMed Report error

205/255 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Dampier W, Berman R, Nonnemacher MR, Wigdahl B. Computational analysis of cas proteins unlocks new potential in HIV-1 targeted gene therapy. Frontiers in Genome Editing. 5: 1248982. PMID 38239625 DOI: 10.3389/fgeed.2023.1248982  0.635
2023 Allen AG, Chung CH, Worrell SD, Nwaozo G, Madrid R, Mele AR, Dampier W, Nonnemacher MR, Wigdahl B. Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9. Frontiers in Genome Editing. 5: 1101483. PMID 37124096 DOI: 10.3389/fgeed.2023.1101483  0.705
2023 Lawrence JM, Schardien K, Wigdahl B, Nonnemacher MR. Roles of neuropathology-associated reactive astrocytes: a systematic review. Acta Neuropathologica Communications. 11: 42. PMID 36915214 DOI: 10.1186/s40478-023-01526-9  0.542
2023 Mohamed H, Berman R, Connors J, Haddad EK, Miller V, Nonnemacher MR, Dampier W, Wigdahl B, Krebs FC. Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy. Biomedicines. 11. PMID 36672628 DOI: 10.3390/biomedicines11010122  0.708
2022 Marino J, Maubert ME, Lawrence JM, Wigdahl B, Nonnemacher MR. Chronic Low Dose Morphine Does Not Alter Two In Vitro BBB Models. Brain Sciences. 12. PMID 35884695 DOI: 10.3390/brainsci12070888  0.59
2022 Mohamed H, Gurrola T, Berman R, Collins M, Sariyer IK, Nonnemacher MR, Wigdahl B. Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy. Frontiers in Immunology. 12: 816515. PMID 35126374 DOI: 10.3389/fimmu.2021.816515  0.706
2021 Atkins A, Chung CH, Allen AG, Dampier W, Gurrola TE, Sariyer IK, Nonnemacher MR, Wigdahl B. Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy. Frontiers in Genome Editing. 3: 673022. PMID 34713260 DOI: 10.3389/fgeed.2021.673022  0.618
2021 Chung CH, Allen AG, Atkins A, Link RW, Nonnemacher MR, Dampier W, Wigdahl B. Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy. Frontiers in Cellular and Infection Microbiology. 11: 593077. PMID 33768011 DOI: 10.3389/fcimb.2021.593077  0.674
2021 Mohamed H, Clemen R, Freund E, Lackmann JW, Wende K, Connors J, Haddad EK, Dampier W, Wigdahl B, Miller V, Bekeschus S, Krebs FC. Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection. Plos One. 16: e0247125. PMID 33647028 DOI: 10.1371/journal.pone.0247125  0.479
2020 Atkins AJ, Allen AG, Dampier W, Haddad EK, Nonnemacher MR, Wigdahl B. HIV-1 cure strategies: Why CRISPR? Expert Opinion On Biological Therapy. PMID 33331178 DOI: 10.1080/14712598.2021.1865302  0.685
2020 Sullivan NT, Allen AG, Atkins AJ, Chung CH, Dampier W, Nonnemacher MR, Wigdahl B. Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing. Frontiers in Microbiology. 11: 1872. PMID 32903440 DOI: 10.3389/Fmicb.2020.01872  0.675
2020 Chung CH, Allen AG, Atkins AJ, Sullivan NT, Homan G, Costello R, Madrid R, Nonnemacher MR, Dampier W, Wigdahl B. Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites. Molecular Therapy. Nucleic Acids. 21: 965-982. PMID 32818921 DOI: 10.1016/J.Omtn.2020.07.016  0.74
2020 Marino J, Wigdahl B, Nonnemacher MR. Extracellular HIV-1 Tat Mediates Increased Glutamate in the CNS Leading to Onset of Senescence and Progression of HAND. Frontiers in Aging Neuroscience. 12: 168. PMID 32581774 DOI: 10.3389/Fnagi.2020.00168  0.725
2020 Marino J, Maubert ME, Mele AR, Spector C, Wigdahl B, Nonnemacher MR. Functional impact of HIV-1 Tat on cells of the CNS and its role in HAND. Cellular and Molecular Life Sciences : Cmls. PMID 32577796 DOI: 10.1007/S00018-020-03561-4  0.732
2020 Mohamed H, Miller V, Jennings SR, Wigdahl B, Krebs FC. The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook. Journal of Immunology Research. 2020: 9470102. PMID 32537473 DOI: 10.1155/2020/9470102  0.523
2020 Chung CH, Mele AR, Allen AG, Costello R, Dampier W, Nonnemacher MR, Wigdahl B. Integrated Human Immunodeficiency Virus Type 1 Sequence in J-Lat 10.6. Microbiology Resource Announcements. 9. PMID 32354973 DOI: 10.1128/MRA.00179-20  0.617
2020 Mele AR, Marino J, Dampier W, Wigdahl B, Nonnemacher MR. HIV-1 Tat Length: Comparative and Functional Considerations. Frontiers in Microbiology. 11: 444. PMID 32265877 DOI: 10.3389/Fmicb.2020.00444  0.698
2019 Sullivan NT, Dampier W, Chung CH, Allen AG, Atkins A, Pirrone V, Homan G, Passic S, Williams J, Zhong W, Kercher K, Desimone M, Li L, C Antell G, Mell JC, ... ... Wigdahl B, et al. Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients. Scientific Reports. 9: 17088. PMID 31745112 DOI: 10.1038/S41598-019-52353-9  0.722
2019 Chung CH, Allen AG, Sullivan NT, Atkins A, Nonnemacher MR, Wigdahl B, Dampier W. Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31672284 DOI: 10.1016/J.Ymthe.2019.10.008  0.58
2019 Link RW, Mele AR, Antell GC, Pirrone V, Zhong W, Kercher K, Passic S, Szep Z, Malone K, Jacobson JM, Dampier W, Wigdahl B, Nonnemacher MR. Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort. Virus Research. 197727. PMID 31437485 DOI: 10.1016/J.Virusres.2019.197727  0.663
2019 Spector C, Mele AR, Wigdahl B, Nonnemacher MR. Genetic variation and function of the HIV-1 Tat protein. Medical Microbiology and Immunology. PMID 30834965 DOI: 10.1007/S00430-019-00583-Z  0.737
2019 Wigdahl B, Chung C-, Allen AG, Atkins AJ, Costello R, Sullivan NT, Nonnemacher MR, Dampier WN. CRISPR/Cas9 editing of HIV-1 transcription factor binding sites on the 5’ long terminal repeats to permanently inactivate latent provirus Journal of Virus Eradication. 5: 54-55. DOI: 10.1016/S2055-6640(20)30218-1  0.698
2019 Wigdahl B, Allen A, Worell S, Nwaozo G, Madrid R, Dampier W, Nonnemacher M. Broad-spectrum gRNAs abolish HIV-1 LTR-mediated transcription in cells that receive CRISPR/Cas9 therapy Journal of Virus Eradication. 5: 54. DOI: 10.1016/S2055-6640(20)30217-X  0.707
2018 Link RW, Nonnemacher MR, Wigdahl B, Dampier W. Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy. The Crispr Journal. 1: 294-302. PMID 31021222 DOI: 10.1089/crispr.2018.0020  0.681
2018 Allen AG, Chung CH, Atkins A, Dampier W, Khalili K, Nonnemacher MR, Wigdahl B. Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection. Frontiers in Microbiology. 9: 2940. PMID 30619107 DOI: 10.3389/Fmicb.2018.02940  0.748
2018 Dampier W, Sullivan NT, Mell J, Pirrone V, Ehrlich G, Chung CH, Allen AG, DeSimone M, Zhong W, Kercher K, Passic S, Williams J, Szep Z, Khalili K, Jacobson J, ... ... Wigdahl B, et al. Broad spectrum and personalized gRNAs for CRISPR/Cas9 HIV-1 therapeutics. Aids Research and Human Retroviruses. PMID 29968495 DOI: 10.1089/Aid.2017.0274  0.705
2018 Mele AR, Marino J, Chen K, Pirrone V, Janetopoulos C, Wigdahl B, Klase Z, Nonnemacher MR. Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P at the epicenter. Traffic (Copenhagen, Denmark). PMID 29708629 DOI: 10.1111/Tra.12578  0.734
2018 Mumford B, Pirrone V, O’Hayer CV, Dampier W, Wigdahl B, O’Loughlin C, Amat M, Szep Z. 584. Investigation of the Association Between Neurocognitive Function and Depression in HIV Infection Open Forum Infectious Diseases. 5: S215-S215. DOI: 10.1093/Ofid/Ofy210.591  0.441
2017 Dave RS, Sharma RK, Muir RR, Haddad E, Gumber S, Villinger F, Nehra AP, Khan ZK, Wigdahl B, Ansari AA, Byrareddy SN, Jain P. FDC:TFH Interactions within Cervical Lymph Nodes of SIV-Infected Rhesus Macaques. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 29288344 DOI: 10.1007/S11481-017-9775-0  0.474
2017 Egan KP, Allen AG, Wigdahl B, Jennings SR. Modeling the pathology, immune responses, and kinetics of HSV-1 replication in the lip scarification model. Virology. 514: 124-133. PMID 29175626 DOI: 10.1016/J.Virol.2017.11.010  0.346
2017 Liu Y, Nonnemacher MR, Alexaki A, Pirrone V, Banerjee A, Li L, Kilareski E, Wigdahl B. Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site. Clinical Medicine Insights. Pathology. 10: 1179555717694556. PMID 29162980 DOI: 10.1177/1179555717694556  0.666
2017 Dampier W, Sullivan NT, Chung CH, Mell JC, Nonnemacher MR, Wigdahl B. Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants. Scientific Reports. 7: 14413. PMID 29089503 DOI: 10.1038/S41598-017-12612-Z  0.712
2017 Antell GC, Dampier W, Aiamkitsumrit B, Nonnemacher MR, Pirrone V, Zhong W, Kercher K, Passic S, Williams J, Liu Y, James T, Jacobson JM, Szep Z, Wigdahl B, Krebs FC. Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr Sequences. International Journal of Genomics. 2017: 4081585. PMID 28620613 DOI: 10.1155/2017/4081585  0.678
2017 Maubert ME, Wigdahl B, Nonnemacher MR. Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease. Frontiers in Neuroscience. 11: 228. PMID 28491017 DOI: 10.3389/Fnins.2017.00228  0.662
2017 Banerjee A, Li L, Pirrone V, Krebs FC, Wigdahl B, Nonnemacher MR. cAMP Signaling Enhances HIV-1 Long Terminal Repeat (LTR)-directed Transcription and Viral Replication in Bone Marrow Progenitor Cells. Clinical Medicine Insights. Pathology. 10: 1179555717694535. PMID 28469516 DOI: 10.1177/1179555717694535  0.716
2017 Allen A, Sullivan NT, Dampier W, Chung CH, Atkins A, Homan G, Pirrone V, Passic S, Williams J, Szep Z, Jacobson JM, Nonnemacher MR, Wigdahl B. Designing broad-spectrum gRNAs to target the HIV-1 LTR with CRISPR/cas9-based therapeutic strategies Journal of Virus Eradication. 3: 50. DOI: 10.1016/S2055-6640(20)30669-5  0.669
2017 Nonnemacher MR, Mele AR, King KM, Antell G, Dampier W, Tata R, Pirrone V, Williams J, Homan G, Passic S, Kercher K, Zhong W, Szep Z, Jacobson J, Wigdahl B, et al. Examining functional alterations of HIV-1 Tat variants associated with neurocognitively impaired patients in the Drexel Medicine CARES Cohort Journal of Virus Eradication. 3: 24. DOI: 10.1016/S2055-6640(20)30624-5  0.668
2016 Azar A, Devlin K, Mell JC, Giovannetti T, Pirrone V, Nonnemacher MR, Passic S, Kercher K, Williams JW, Jacobson JM, Wigdahl B, Dampier W, Libon DJ, Sell C. Mitochondrial Haplogroup Influences Motor Function in Long-Term HIV-1-Infected Individuals. Plos One. 11: e0163772. PMID 27711166 DOI: 10.1016/J.Exger.2017.02.027  0.652
2016 Dampier W, Antell GC, Aiamkitsumrit B, Nonnemacher MR, Jacobson JM, Pirrone V, Zhong W, Kercher K, Passic S, Williams JW, James T, Devlin KN, Giovannetti T, Libon DJ, Szep Z, ... ... Wigdahl B, et al. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status. Journal of Neurovirology. PMID 27400931 DOI: 10.1007/S13365-016-0462-3  0.719
2016 Strazza M, Pirrone V, Wigdahl B, Dampier W, Lin W, Feng R, Maubert ME, Weksler B, Romero IA, Couraud PO, Nonnemacher MR. Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood-Brain Barrier. International Journal of Molecular Sciences. 17. PMID 27294916 DOI: 10.3390/Ijms17060916  0.601
2016 Strazza M, Maubert ME, Pirrone V, Wigdahl B, Nonnemacher MR. Co-culture model consisting of human brain microvascular endothelial and peripheral blood mononuclear cells. Journal of Neuroscience Methods. PMID 27216631 DOI: 10.1016/J.Jneumeth.2016.05.016  0.585
2016 Dampier W, Nonnemacher MR, Mell J, Earl J, Ehrlich GD, Pirrone V, Aiamkitsumrit B, Zhong W, Kercher K, Passic S, Williams JW, Jacobson JM, Wigdahl B. HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients. Plos One. 11: e0155382. PMID 27195985 DOI: 10.1371/Journal.Pone.0155382  0.708
2016 Antell GC, Dampier W, Aiamkitsumrit B, Nonnemacher MR, Jacobson JM, Pirrone V, Zhong W, Kercher K, Passic S, Williams JW, Schwartz G, Hershberg U, Krebs FC, Wigdahl B. Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures. Retrovirology. 13: 32. PMID 27143130 DOI: 10.1186/S12977-016-0266-9  0.683
2016 Nonnemacher MR, Pirrone V, Feng R, Moldover B, Passic S, Aiamkitsumrit B, Dampier W, Wojno A, Kilareski E, Blakey B, Ku TS, Shah S, Sullivan NT, Jacobson JM, Wigdahl B. HIV-1 Promoter Single Nucleotide Polymorphisms Are Associated with Clinical Disease Severity. Plos One. 11: e0150835. PMID 27100290 DOI: 10.1371/Journal.Pone.0150835  0.718
2016 James T, Nonnemacher MR, Wigdahl B, Krebs FC. Defining the roles for Vpr in HIV-1-associated neuropathogenesis. Journal of Neurovirology. PMID 27056720 DOI: 10.1007/S13365-016-0436-5  0.761
2016 Datta PK, Kaminski R, Hu W, Pirrone V, Sullivan NT, Nonnemacher MR, Dampier W, Wigdahl B, Khalili K. HIV-1 Latency and Eradication: Past, Present and Future. Current Hiv Research. PMID 27009094 DOI: 10.2174/1570162X14666160324125536  0.747
2016 Wigdahl B. Coinfection with Hepatitis C Virus among HIV-1-Infected Individuals Increases Proinflammatory Cytokines and HIV-1 Disease Severity Moj Immunology. 4. DOI: 10.15406/Moji.2016.04.00115  0.532
2015 Maubert ME, Pirrone V, Rivera NT, Wigdahl B, Nonnemacher MR. Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System Disease. Frontiers in Microbiology. 6: 1512. PMID 26793168 DOI: 10.3389/Fmicb.2015.01512  0.725
2015 Aiamkitsumrit B, Sullivan NT, Nonnemacher MR, Pirrone V, Wigdahl B. Human Immunodeficiency Virus Type 1 Cellular Entry and Exit in the T Lymphocytic and Monocytic Compartments: Mechanisms and Target Opportunities During Viral Disease. Advances in Virus Research. 93: 257-311. PMID 26111588 DOI: 10.1016/Bs.Aivir.2015.04.001  0.675
2015 Keogan S, Siegert K, Wigdahl B, Krebs FC. Critical Review: Immunomodulation by Seminal Factors and Implications for Male-to-Female HIV-1 Transmission. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 131-7. PMID 25642971 DOI: 10.1097/Qai.0000000000000561  0.469
2015 Shah S, Pirrone V, Alexaki A, Nonnemacher MR, Wigdahl B. Impact of viral activators and epigenetic regulators on HIV-1 LTRs containing naturally occurring single nucleotide polymorphisms. Biomed Research International. 2015: 320642. PMID 25629043 DOI: 10.1155/2015/320642  0.73
2015 Kollias CM, Huneke RB, Wigdahl B, Jennings SR. Animal models of herpes simplex virus immunity and pathogenesis. Journal of Neurovirology. 21: 8-23. PMID 25388226 DOI: 10.1007/S13365-014-0302-2  0.364
2015 Wigdahl B. Impact of Naturally Occurring Genetic Variation in the HIV-1 LTR TAR Region and Sp Binding Sites on Tat-Mediated Transcription Journal of Human Virology & Retrovirology. 2. DOI: 10.15406/Jhvrv.2015.02.00052  0.515
2015 Dampier W, Chung CH, Nonnemacher MR, Wigdahl B. Computational detection of off-target effects of CRISPR/Cas9-associated gRNAs Journal of Virus Eradication. 1: 39-40. DOI: 10.1016/S2055-6640(20)31410-2  0.545
2015 Sullivan NT, Nonnemacher MR, Pirrone V, Feng R, Moldover B, Dampier W, Passic S, Williams J, Aiamkitsumrit B, Zhong W, Blakey B, Shah S, Jacobson JM, Wigdahl B. SNPs within the HIV-1 LTR associate with increased virus persistence Journal of Virus Eradication. 1: 26. DOI: 10.1016/S2055-6640(20)31384-4  0.698
2015 Devlin KN, Giovannetti T, Dampier W, Pirrone V, Nonnemacher MR, Schell E, Lamberson C, Kurczewski JR, Jacobson JM, Libon DJ, Wigdahl B. Mild cognitive impairment in a clinically latent HIV-1 patient population Journal of Virus Eradication. 1: 24. DOI: 10.1016/S2055-6640(20)31379-0  0.641
2015 Dampier W, Nonnemacher MR, Mell JC, Earl J, Pirrone V, Aiamkitsumrit B, Zhong W, Kercher K, Passic S, Williams JW, Jacobson JM, Wigdahl B. Genetic variation continues to occur in well-controlled HIV-1-infected patients Journal of Virus Eradication. 1: 42. DOI: 10.1016/S2055-6640(20)31349-2  0.677
2015 Nonnemacher M, Dampier W, Desimone M, Pirrone V, Kercher K, Passic S, Williams J, Wigdahl B. Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies Journal of Virus Eradication. 1: 42. DOI: 10.1016/S2055-6640(20)31347-9  0.691
2014 Alexaki A, Quiterio SJ, Nonnemacher MR, Shah S, Liu Y, Banerjee A, Li L, Passic S, Pirrone V, Kilareski E, Petrovas C, Wigdahl B. Modeling Bone Marrow Progenitor Cell Differentiation and Susceptibility to HIV-1 Infection. Moj Immunology. 1: 00009-9. PMID 26229980 DOI: 10.15406/Moji.2014.01.00009  0.839
2014 Pirrone V, Mell J, Janto B, Wigdahl B. Biomarkers of HIV Susceptibility and Disease Progression. Ebiomedicine. 1: 99-100. PMID 26137515 DOI: 10.1016/J.Ebiom.2014.11.003  0.476
2014 Dampier W, Nonnemacher MR, Sullivan NT, Jacobson JM, Wigdahl B. HIV Excision Utilizing CRISPR/Cas9 Technology: Attacking the Proviral Quasispecies in Reservoirs to Achieve a Cure. Moj Immunology. 1. PMID 25893217 DOI: 10.15406/Moji.2014.01.00022  0.708
2014 Strazza M, Banerjee A, Alexaki A, Passic SR, Meucci O, Pirrone V, Wigdahl B, Nonnemacher MR. Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells. Bmc Research Notes. 7: 752. PMID 25338959 DOI: 10.1186/1756-0500-7-752  0.673
2014 Aiamkitsumrit B, Dampier W, Martin-Garcia J, Nonnemacher MR, Pirrone V, Ivanova T, Zhong W, Kilareski E, Aldigun H, Frantz B, Rimbey M, Wojno A, Passic S, Williams JW, Shah S, ... ... Wigdahl B, et al. Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences. Plos One. 9: e107389. PMID 25265194 DOI: 10.1371/Journal.Pone.0107389  0.684
2014 Fraietta JA, Mueller YM, Lozenski KL, Ratner D, Boesteanu AC, Hancock AS, Lackman-Smith C, Zentner IJ, Chaiken IM, Chung S, LeGrice SF, Snyder BA, Mankowski MK, Jones NM, Hope JL, ... ... Wigdahl B, et al. Abasic phosphorothioate oligomers inhibit HIV-1 reverse transcription and block virus transmission across polarized ectocervical organ cultures. Antimicrobial Agents and Chemotherapy. 58: 7056-71. PMID 25224013 DOI: 10.1128/Aac.02991-14  0.539
2014 Shah S, Alexaki A, Pirrone V, Dahiya S, Nonnemacher MR, Wigdahl B. Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I. Virology Journal. 11: 92. PMID 24886416 DOI: 10.1186/1743-422X-11-92  0.719
2014 Aiamkitsumrit B, Dampier W, Antell G, Rivera N, Martin-Garcia J, Pirrone V, Nonnemacher MR, Wigdahl B. Bioinformatic analysis of HIV-1 entry and pathogenesis. Current Hiv Research. 12: 132-61. PMID 24862329 DOI: 10.2174/1570162X12666140526121746  0.714
2014 Sagar D, Masih S, Schell T, Jacobson S, Comber JD, Philip R, Wigdahl B, Jain P, Khan ZK. In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine. Vaccine. 32: 3274-84. PMID 24739247 DOI: 10.1016/J.Vaccine.2014.03.087  0.332
2014 Parikh N, Dampier W, Feng R, Passic SR, Zhong W, Frantz B, Blakey B, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Jacobson JM, Wigdahl B. Cocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 256-64. PMID 24732878 DOI: 10.1097/Qai.0000000000000163  0.684
2014 Dahiya S, Liu Y, Nonnemacher MR, Dampier W, Wigdahl B. CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage. Plos One. 9: e88116. PMID 24551078 DOI: 10.1371/Journal.Pone.0088116  0.733
2014 Wigdahl B. Role of Downstream Elements in Transcriptional Regulation of the HIV-1 Promoter Journal of Human Virology & Retrovirology. 1. DOI: 10.15406/Jhvrv.2014.01.00006  0.509
2014 Antell G, Nonnemacher MR, Pirrone V, Wigdahl B. Role of retrovirus-induced transactivator proteins in neuroinflammatory disease Neuroinflammation and Neurodegeneration. 355-385. DOI: 10.1007/978-1-4939-1071-7_17  0.708
2013 Shirazi J, Shah S, Sagar D, Nonnemacher MR, Wigdahl B, Khan ZK, Jain P. Epigenetics, drugs of abuse, and the retroviral promoter. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 1181-96. PMID 24218017 DOI: 10.1007/S11481-013-9508-Y  0.648
2013 Egan KP, Wu S, Wigdahl B, Jennings SR. Immunological control of herpes simplex virus infections. Journal of Neurovirology. 19: 328-45. PMID 23943467 DOI: 10.1007/S13365-013-0189-3  0.402
2013 Dahiya S, Irish BP, Nonnemacher MR, Wigdahl B. Genetic variation and HIV-associated neurologic disease. Advances in Virus Research. 87: 183-240. PMID 23809924 DOI: 10.1016/B978-0-12-407698-3.00006-5  0.724
2013 Ferrucci A, Nonnemacher MR, Wigdahl B. Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival. Journal of Neurovirology. 19: 239-53. PMID 23728617 DOI: 10.1007/S13365-013-0170-1  0.72
2013 Pirrone V, Libon DJ, Sell C, Lerner CA, Nonnemacher MR, Wigdahl B. Impact of age on markers of HIV-1 disease. Future Virology. 8: 81-101. PMID 23596462 DOI: 10.2217/Fvl.12.127  0.693
2013 Joseph J, Achim CL, Boivin MJ, Brew BJ, Clifford DB, Colosi DA, Ellis RJ, Heaton RK, Gallo-Diop A, Grant I, Kanmogne GD, Kumar M, Letendre S, Marcotte TD, Nath A, ... ... Wigdahl B, et al. Global NeuroAIDS roundtable. Journal of Neurovirology. 19: 1-9. PMID 23354550 DOI: 10.1007/S13365-012-0143-9  0.488
2012 Lozenski K, Ownbey R, Wigdahl B, Kish-Catalone T, Krebs FC. Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety. Bmc Pharmacology & Toxicology. 13: 9. PMID 23025553 DOI: 10.1186/2050-6511-13-9  0.346
2012 Parikh N, Nonnemacher MR, Pirrone V, Block T, Mehta A, Wigdahl B. Substance abuse, HIV-1 and hepatitis. Current Hiv Research. 10: 557-71. PMID 22973853 DOI: 10.2174/157016212803306023  0.688
2012 Li L, Dahiya S, Kortagere S, Aiamkitsumrit B, Cunningham D, Pirrone V, Nonnemacher MR, Wigdahl B. Impact of Tat Genetic Variation on HIV-1 Disease. Advances in Virology. 2012: 123605. PMID 22899925 DOI: 10.1155/2012/123605  0.734
2012 Ferrucci A, Nonnemacher MR, Cohen EA, Wigdahl B. Extracellular human immunodeficiency virus type 1 viral protein R causes reductions in astrocytic ATP and glutathione levels compromising the antioxidant reservoir. Virus Research. 167: 358-69. PMID 22691542 DOI: 10.1016/J.Virusres.2012.06.002  0.71
2012 Gerrard SE, Baniecki ML, Sokal DC, Morris MK, Urdaneta-Hartmann S, Krebs FC, Wigdahl B, Abrams BF, Hanson CV, Slater NK, Edwards AD. A nipple shield delivery system for oral drug delivery to breastfeeding infants: microbicide delivery to inactivate HIV. International Journal of Pharmaceutics. 434: 224-34. PMID 22634141 DOI: 10.1016/J.Ijpharm.2012.05.035  0.405
2012 Dahiya S, Nonnemacher MR, Wigdahl B. Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development. The Journal of General Virology. 93: 1151-72. PMID 22422068 DOI: 10.1099/Vir.0.041186-0  0.745
2012 Pirrone V, Passic S, Wigdahl B, Krebs FC. Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1. Virology Journal. 9: 33. PMID 22281044 DOI: 10.1186/1743-422X-9-33  0.538
2012 Kogan M, Haine V, Ke Y, Wigdahl B, Fischer-Smith T, Rappaport J. Macrophage colony stimulating factor regulation by nuclear factor kappa B: a relevant pathway in human immunodeficiency virus type 1 infected macrophages. Dna and Cell Biology. 31: 280-9. PMID 21895511 DOI: 10.1089/Dna.2011.1357  0.47
2012 Hartmann SU, Krebs F, Wigdahl B, Sokal D, Baniecki ML, Owen D, Gerrard S, Kneen E. A Microbicidal Nipple Shield: An Innovative Method for Prevention of Mother-to-Child Transmission Of HIV Through Breastfeeding Gender Medicine. 9: S95. DOI: 10.1016/J.Genm.2011.09.007  0.412
2012 Krebs F, Pirrone V, Passic S, Wigdahl B. In Vitro Enhancement of HIV-1 Infection as a Potential Contributor to the Clinical Failures of Select Polyanionic Microbicide Candidates Gender Medicine. 9: S94. DOI: 10.1016/J.Genm.2011.09.004  0.465
2012 Keogan S, Passic S, Wigdahl B, Krebs F. Cationic Cell Penetrating Peptides as Potential Inhibitors of HIV-1 Infection Gender Medicine. 9: S94. DOI: 10.1016/J.Genm.2011.09.003  0.47
2011 Lozenski K, Kish-Catalone T, Pirrone V, Rando RF, Labib M, Wigdahl B, Krebs FC. Cervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine model Journal of Biomedicine and Biotechnology. 2011. PMID 22131821 DOI: 10.1155/2011/941061  0.415
2011 Ferrucci A, Nonnemacher MR, Wigdahl B. Human immunodeficiency virus viral protein R as an extracellular protein in neuropathogenesis. Advances in Virus Research. 81: 165-99. PMID 22094081 DOI: 10.1016/B978-0-12-385885-6.00010-9  0.724
2011 Ferrucci A, Nonnemacher MR, Wigdahl B. Cellular phenotype impacts human immunodeficiency virus type 1 viral protein R subcellular localization. Virology Journal. 8: 397. PMID 21831263 DOI: 10.1186/1743-422X-8-397  0.737
2011 Banerjee A, Strazza M, Wigdahl B, Pirrone V, Meucci O, Nonnemacher MR. Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis. Journal of Neurovirology. 17: 291-302. PMID 21735315 DOI: 10.1007/S13365-011-0037-2  0.712
2011 Banerjee A, Pirrone V, Wigdahl B, Nonnemacher MR. Transcriptional regulation of the chemokine co-receptor CCR5 by the cAMP/PKA/CREB pathway. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 65: 293-7. PMID 21719243 DOI: 10.1016/J.Biopha.2011.03.009  0.69
2011 Strazza M, Pirrone V, Wigdahl B, Nonnemacher MR. Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. Brain Research. 1399: 96-115. PMID 21641584 DOI: 10.1016/J.Brainres.2011.05.015  0.744
2011 Pirrone V, Wigdahl B, Krebs FC. The rise and fall of polyanionic inhibitors of the human immunodeficiency virus type 1. Antiviral Research. 90: 168-82. PMID 21439325 DOI: 10.1016/J.Antiviral.2011.03.176  0.504
2011 Pirrone V, Thakkar N, Jacobson JM, Wigdahl B, Krebs FC. Combinatorial approaches to the prevention and treatment of HIV-1 infection. Antimicrobial Agents and Chemotherapy. 55: 1831-42. PMID 21343462 DOI: 10.1128/Aac.00976-10  0.537
2011 Li L, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Wojno A, Passic S, Flaig K, Kilareski E, Blakey B, Ku J, Parikh N, Shah R, Martin-Garcia J, Moldover B, Servance L, ... ... Wigdahl B, et al. Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment. Journal of Neurovirology. 17: 92-109. PMID 21225391 DOI: 10.1007/S13365-010-0014-1  0.706
2011 Guo H, Pan X, Mao R, Zhang X, Wang L, Lu X, Chang J, Guo JT, Passic S, Krebs FC, Wigdahl B, Warren TK, Retterer CJ, Bavari S, Xu X, et al. Alkylated porphyrins have broad antiviral activity against hepadnaviruses, flaviviruses, filoviruses, and arenaviruses. Antimicrobial Agents and Chemotherapy. 55: 478-86. PMID 21135183 DOI: 10.1128/Aac.00989-10  0.371
2011 Rahman S, Khan ZK, Wigdahl B, Jennings SR, Tangy F, Jain P. Murine FLT3 ligand-derived dendritic cell-mediated early immune responses are critical to controlling cell-free human T cell leukemia virus type 1 infection. Journal of Immunology (Baltimore, Md. : 1950). 186: 390-402. PMID 21115731 DOI: 10.4049/Jimmunol.1002570  0.422
2011 Rahman S, Manuel SL, Khan ZK, Wigdahl B, Tangy F, Jain P. Depletion of dendritic cells enhances susceptibility to cell-free but not cell-associated HTLV-1 infection in CD11c-DTR transgenic mice Retrovirology. 8: 1-1. DOI: 10.1186/1742-4690-8-S1-A25  0.421
2011 Rahman S, Khan ZK, Wigdahl B, Jennings SR, Tangy F, Jain P. Murine Flt3L-derived dendritic cell mediated early immune responses are critical to controlling cell-free HTLV-1 infection Retrovirology. 8: A188. DOI: 10.1186/1742-4690-8-S1-A188  0.419
2010 Passic SR, Ferguson ML, Catalone BJ, Kish-Catalone T, Kholodovych V, Zhu W, Welsh W, Rando R, Howett MK, Wigdahl B, Labib M, Krebs FC. Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1 Biomedicine and Pharmacotherapy. 64: 723-732. PMID 21106331 DOI: 10.1016/J.Biopha.2010.10.001  0.834
2010 Liu Y, Nonnemacher MR, Stauff DL, Li L, Banerjee A, Irish B, Kilareski E, Rajagopalan N, Suchitra JB, Khan ZK, Ranga U, Wigdahl B. Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 64: 672-80. PMID 20970301 DOI: 10.1016/J.Biopha.2010.09.007  0.69
2010 Rosa Borges A, Wieczorek L, Johnson B, Benesi AJ, Brown BK, Kensinger RD, Krebs FC, Wigdahl B, Blumenthal R, Puri A, McCutchan FE, Birx DL, Polonis VR, Schengrund CL. Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1. Virology. 408: 80-8. PMID 20880566 DOI: 10.1016/J.Virol.2010.09.004  0.56
2010 Pirrone V, Passic S, Wigdahl B, Rando RF, Labib M, Krebs FC. A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection. Journal of Biomedicine & Biotechnology. 2010: 548749. PMID 20589074 DOI: 10.1155/2010/548749  0.533
2010 Shah S, Nonnemacher MR, Pirrone V, Wigdahl B. Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 5: 278-93. PMID 20387125 DOI: 10.1007/S11481-010-9207-X  0.733
2010 Rahman S, Manuel SL, Khan ZK, Wigdahl B, Acheampong E, Tangy F, Jain P. Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice. Journal of Immunology (Baltimore, Md. : 1950). 184: 5553-61. PMID 20382884 DOI: 10.4049/Jimmunol.0903226  0.427
2010 Thakkar N, Pirrone V, Passic S, Keogan S, Zhu W, Kholodovych V, Welsh W, Rando R, Labib M, Wigdahl B, Krebs FC. Persistent interactions between biguanide-based compound NB325 and CXCR4 result in prolonged inhibition of human immunodeficiency virus type 1 infection. Antimicrobial Agents and Chemotherapy. 54: 1965-72. PMID 20231400 DOI: 10.1128/Aac.00934-09  0.522
2010 Banerjee A, Nonnemacher MR, Wigdahl B. HIV latency and reactivation: Role in neuropathogenesis Chemokine Receptors and Neuroaids: Beyond Co-Receptor Function and Links to Other Neuropathologies. 87-118. DOI: 10.1007/978-1-4419-0793-6_5  0.704
2009 Irish BP, Khan ZK, Jain P, Nonnemacher MR, Pirrone V, Rahman S, Rajagopalan N, Suchitra JB, Mostoller K, Wigdahl B. Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review. American Journal of Infectious Diseases. 5: 231-258. PMID 20352020 DOI: 10.3844/Ajidsp.2009.231.258  0.858
2009 Rajagopalan N, Suchitra JB, Shet A, Khan ZK, Martin-Garcia J, Nonnemacher MR, Jacobson JM, Wigdahl B. Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatients at a Community Care Center. American Journal of Infectious Diseases. 5: 219-224. PMID 20204076 DOI: 10.3844/Ajidsp.2009.219.224  0.651
2009 Kilareski EM, Shah S, Nonnemacher MR, Wigdahl B. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology. 6: 118. PMID 20030845 DOI: 10.1186/1742-4690-6-118  0.736
2009 Jain P, Manuel SL, Khan ZK, Ahuja J, Quann K, Wigdahl B. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. Journal of Virology. 83: 10908-21. PMID 19692463 DOI: 10.1128/Jvi.01054-09  0.379
2009 Liu Y, Nonnemacher MR, Wigdahl B. CCAAT/enhancer-binding proteins and the pathogenesis of retrovirus infection. Future Microbiology. 4: 299-321. PMID 19327116 DOI: 10.2217/Fmb.09.4  0.74
2009 Thakkar N, Pirrone V, Passic S, Zhu W, Kholodovych V, Welsh W, Rando RF, Labib ME, Wigdahl B, Krebs FC. Specific interactions between the viral coreceptor CXCR4 and the biguanide-based compound NB325 mediate inhibition of human immunodeficiency virus type 1 infection. Antimicrobial Agents and Chemotherapy. 53: 631-8. PMID 19047650 DOI: 10.1128/Aac.00866-08  0.492
2009 Pirrone V, Passic S, Wigdahl B, Krebs F. Clinical Failures of Select Polyanionic Microbicide Candidates may be Predicted by In Vitro Enhancement of HIV-1 Infection Antiviral Research. 82: A65-A66. DOI: 10.1016/J.Antiviral.2009.02.159  0.448
2009 Passic S, Pirrone V, Wigdahl B, Doncel G, Krebs F. Using the Conrad Testing Algorithm to Evaluate the Cytotoxicity and Anti-HIV-1 Activity of Candidate Microbicide Compounds Antiviral Research. 82: A65. DOI: 10.1016/J.Antiviral.2009.02.158  0.398
2009 Keogan S, Pirrone V, Passic S, Wigdahl B, Krebs F. Induction of HIV-1 Gene Expression in Human Monocytic Cells by the Failed Microbicide Carrageenan Occurs Through Activation of Toll-like Receptor 4 (TLR4) Antiviral Research. 82: A64. DOI: 10.1016/J.Antiviral.2009.02.154  0.463
2009 Thakkar N, Pirrone V, Passic S, Labib M, Rando R, Wigdahl B, Krebs F. Immediate and Persistent Anti-HIV-1 Activity of the Biguanide-based Compound NB325 Involves Specific Interactions with the Viral Co-receptor CXCR4 Antiviral Research. 82: A26. DOI: 10.1016/J.Antiviral.2009.02.041  0.455
2008 Alexaki A, Wigdahl B. HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. Plos Pathogens. 4: e1000215. PMID 19112504 DOI: 10.1371/Journal.Ppat.1000215  0.569
2008 Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Current Hiv Research. 6: 388-400. PMID 18855649 DOI: 10.2174/157016208785861195  0.586
2008 Mukhtar M, Arshad M, Ahmad M, Pomerantz RJ, Wigdahl B, Parveen Z. Antiviral potentials of medicinal plants. Virus Research. 131: 111-20. PMID 17981353 DOI: 10.1016/J.Virusres.2007.09.008  0.359
2007 Jain P, Mostoller K, Flaig KE, Ahuja J, Lepoutre V, Alefantis T, Khan ZK, Wigdahl B. Identification of human T cell leukemia virus type 1 tax amino acid signals and cellular factors involved in secretion of the viral oncoprotein. The Journal of Biological Chemistry. 282: 34581-93. PMID 17897946 DOI: 10.1074/Jbc.M707317200  0.808
2007 Alexaki A, Quiterio SJ, Liu Y, Irish B, Kilareski E, Nonnemacher MR, Wigdahl B. PMA-induced differentiation of a bone marrow progenitor cell line activates HIV-1 LTR-driven transcription. Dna and Cell Biology. 26: 387-94. PMID 17570762 DOI: 10.1089/Dna.2006.0542  0.841
2007 Parveen Z, Acheampong E, Pomerantz RJ, Jacobson JM, Wigdahl B, Mukhtar M. Effects of highly active antiretroviral therapy on HIV-1-associated oral complications. Current Hiv Research. 5: 281-92. PMID 17504170 DOI: 10.2174/157016207780636533  0.507
2007 Jain P, Ahuja J, Khan ZK, Shimizu S, Meucci O, Jennings SR, Wigdahl B. Modulation of dendritic cell maturation and function by the Tax protein of human T cell leukemia virus type 1. Journal of Leukocyte Biology. 82: 44-56. PMID 17442856 DOI: 10.1189/Jlb.1006641  0.389
2007 Alefantis T, Flaig KE, Wigdahl B, Jain P. Interaction of HTLV-1 Tax protein with calreticulin: implications for Tax nuclear export and secretion. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 61: 194-200. PMID 17395420 DOI: 10.1016/J.Biopha.2007.02.005  0.775
2007 Ahuja J, Lepoutre V, Wigdahl B, Khan ZK, Jain P. Induction of pro-inflammatory cytokines by human T-cell leukemia virus type-1 Tax protein as determined by multiplexed cytokine protein array analyses of human dendritic cells. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 61: 201-8. PMID 17391906 DOI: 10.1016/J.Biopha.2007.02.006  0.398
2007 Kampani K, Quann K, Ahuja J, Wigdahl B, Khan ZK, Jain P. A novel high throughput quantum dot-based fluorescence assay for quantitation of virus binding and attachment. Journal of Virological Methods. 141: 125-32. PMID 17204339 DOI: 10.1016/J.Jviromet.2006.11.043  0.395
2007 Acheampong E, Parveen Z, Mengistu A, Ngoubilly N, Wigdahl B, Lossinsky AS, Pomerantz RJ, Mukhtar M. Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro. Journal of Virology. 81: 1492-501. PMID 17108035 DOI: 10.1128/Jvi.01843-06  0.5
2007 Pandya D, Rahman S, Wigdahl B, Khan ZK, Jain P. New insights into the pathogenesis, diagnosis and treatment of human T-cell leukemia virus type 1-induced disease Future Virology. 2: 481-493. DOI: 10.2217/17460794.2.5.481  0.401
2006 Grant C, Jain P, Nonnemacher M, Flaig KE, Irish B, Ahuja J, Alexaki A, Alefantis T, Wigdahl B. AP-1-directed human T cell leukemia virus type 1 viral gene expression during monocytic differentiation. Journal of Leukocyte Biology. 80: 640-50. PMID 16829632 DOI: 10.1189/Jlb.1205723  0.825
2006 Yao J, Grant C, Harhaj E, Nonnemacher M, Alefantis T, Martin J, Jain P, Wigdahl B. Regulation of human T-cell leukemia virus type 1 gene expression by Sp1 and Sp3 interaction with TRE-1 repeat III. Dna and Cell Biology. 25: 262-76. PMID 16716116 DOI: 10.1089/Dna.2006.25.262  0.782
2006 Ahuja J, Kampani K, Datta S, Wigdahl B, Flaig KE, Jain P. Use of human antigen presenting cell gene array profiling to examine the effect of human T-cell leukemia virus type 1 Tax on primary human dendritic cells. Journal of Neurovirology. 12: 47-59. PMID 16595374 DOI: 10.1080/13550280600614981  0.408
2006 Hartmann SU, Wigdahl B, Neely EB, Berlin CM, Schengrund CL, Lin HM, Howett MK. Biochemical analysis of human milk treated with sodium dodecyl sulfate, an alkyl sulfate microbicide that inactivates human immunodeficiency virus type 1. Journal of Human Lactation : Official Journal of International Lactation Consultant Association. 22: 61-74. PMID 16467288 DOI: 10.1177/0890334405280651  0.516
2006 Grant C, Nonnemacher M, Jain P, Pandya D, Irish B, Williams SC, Wigdahl B. CCAAT/enhancer-binding proteins modulate human T cell leukemia virus type 1 long terminal repeat activation. Virology. 348: 354-69. PMID 16458341 DOI: 10.1016/J.Virol.2005.12.024  0.662
2006 Beer BE, Doncel GF, Krebs FC, Shattock RJ, Fletcher PS, Buckheit RW, Watson K, Dezzutti CS, Cummins JE, Bromley E, Richardson-Harman N, Pallansch LA, Lackman-Smith C, Osterling C, Mankowski M, ... ... Wigdahl B, et al. In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories. Antimicrobial Agents and Chemotherapy. 50: 713-23. PMID 16436731 DOI: 10.1128/Aac.50.2.713-723.2006  0.777
2005 Alefantis T, Jain P, Ahuja J, Mostoller K, Wigdahl B. HTLV-1 Tax nucleocytoplasmic shuttling, interaction with the secretory pathway, extracellular signaling, and implications for neurologic disease. Journal of Biomedical Science. 12: 961-74. PMID 16228291 DOI: 10.1007/S11373-005-9026-X  0.795
2005 Catalone BJ, Miller SR, Ferguson ML, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B. Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 59: 430-7. PMID 16154721 DOI: 10.1016/J.Biopha.2005.07.008  0.829
2005 Krebs FC, Miller SR, Ferguson ML, Labib M, Rando RF, Wigdahl B. Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 59: 438-45. PMID 16154720 DOI: 10.1016/J.Biopha.2005.07.007  0.543
2005 Catalone BJ, Ferguson ML, Miller SR, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B. Prolonged exposure to the candidate microbicide C31G differentially reduces cellular sensitivity to agent re-exposure. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 59: 460-8. PMID 16154719 DOI: 10.1016/J.Biopha.2005.07.009  0.774
2005 Urdaneta S, Wigdahl B, Neely EB, Berlin CM, Schengrund CL, Lin HM, Howett MK. Inactivation of HIV-1 in breast milk by treatment with the alkyl sulfate microbicide sodium dodecyl sulfate (SDS). Retrovirology. 2: 28. PMID 15888210 DOI: 10.1186/1742-4690-2-28  0.486
2005 Catalone BJ, Kish-Catalone TM, Neely EB, Budgeon LR, Ferguson ML, Stiller C, Miller SR, Malamud D, Krebs FC, Howett MK, Wigdahl B. Comparative safety evaluation of the candidate vaginal microbicide C31G. Antimicrobial Agents and Chemotherapy. 49: 1509-20. PMID 15793133 DOI: 10.1128/Aac.49.4.1509-1520.2005  0.766
2005 Harhaj EW, Harhaj NS, Grant C, Mostoller K, Alefantis T, Sun SC, Wigdahl B. Human T cell leukemia virus type I Tax activates CD40 gene expression via the NF-kappa B pathway. Virology. 333: 145-58. PMID 15708600 DOI: 10.1016/J.Virol.2004.12.008  0.792
2005 Alefantis T, Mostoller K, Jain P, Harhaj E, Grant C, Wigdahl B. Secretion of the human T cell leukemia virus type I transactivator protein tax. The Journal of Biological Chemistry. 280: 17353-62. PMID 15659397 DOI: 10.1074/Jbc.M409851200  0.808
2005 Kish-Catalone T, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: S98. DOI: 10.1186/1742-4690-2-S1-S98  0.398
2005 Qian J, Miller S, Ferguson ML, Schlipf L, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: S96. DOI: 10.1186/1742-4690-2-S1-S96  0.519
2005 Pirrone V, Miller S, Ferguson ML, Schlipf L, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: S95. DOI: 10.1186/1742-4690-2-S1-S95  0.533
2005 Banjeree A, Nonnemacher M, Irish B, Wigdahl B. Retrovirology. 2: S157. DOI: 10.1186/1742-4690-2-S1-S157  0.708
2005 Springhetti E, Liu Y, Nonnemacher M, Wigdahl B. Retrovirology. 2: S156. DOI: 10.1186/1742-4690-2-S1-S156  0.701
2005 Liu Y, Nonnemacher M, Alexaki A, Wigdahl B. Retrovirology. 2: S155. DOI: 10.1186/1742-4690-2-S1-S155  0.663
2005 Thakkar N, Miller S, Ferguson ML, Schlipf L, Labib ME, Rando RF, Wigdahl B, Krebs FC. Retrovirology. 2: P94. DOI: 10.1186/1742-4690-2-S1-P94  0.558
2005 Asante A, Nonnemacher M, Alexaki A, Papazoglou E, Lelkes P, Wigdahl B. Retrovirology. 2: P9. DOI: 10.1186/1742-4690-2-S1-P9  0.683
2005 Alexaki A, Nonnemacher M, Wigdahl B. Retrovirology. 2: P8. DOI: 10.1186/1742-4690-2-S1-P8  0.708
2005 Pandya D, Grant CW, Jain P, Wigdahl B. CCAAT/Enhancer-binding Protein-mediated Inhibition of HTLV-1 Viral Gene Expression Retrovirology. 2: 1-1. DOI: 10.1186/1742-4690-2-S1-P79  0.361
2005 Nonnemacher M, Gartner S, Wigdahl B. Retrovirology. 2: P71. DOI: 10.1186/1742-4690-2-S1-P71  0.631
2005 Ahuja J, Jain P, Khan ZK, Wigdahl B. HTLV-1 Tax Protein Induces the Secretion of Th1 Cytokines and β-Chemokines from Dendritic Cells Retrovirology. 2: 7. DOI: 10.1186/1742-4690-2-S1-P7  0.328
2005 Manuel SL, Jain P, Flaig K, Wigdahl B. Analysis of Putative Amino Acid Signals Within Human T Cell Leukemia Virus Type 1 (HTLV-1) Tax Protein Involved in Mediating Tax Secretion Retrovirology. 2: 63. DOI: 10.1186/1742-4690-2-S1-P63  0.303
2005 Li L, Liu Y, Nonnemacher M, Wigdahl B. Retrovirology. 2: P56. DOI: 10.1186/1742-4690-2-S1-P56  0.689
2005 Kampani K, Jain P, Wigdahl B. A High Throughput Quantum Dot-based Fluorescence Assay for Quantitation of HTLV-1 Binding and Attachment Retrovirology. 2: 46. DOI: 10.1186/1742-4690-2-S1-P46  0.349
2005 Jain P, Ahuja J, Kampani K, Khan ZK, Datta S, Wigdahl B. DC-SIGN as a Receptor for HTLV-1 Binding, Entry and Infection Retrovirology. 2: 39. DOI: 10.1186/1742-4690-2-S1-P39  0.369
2005 Jain P, Ahuja J, Khan ZK, Shimizu S, Meucci O, Wigdahl B. Retrovirology. 2: P38. DOI: 10.1186/1742-4690-2-S1-P38  0.359
2005 Irish BP, Nonnemacher MR, Wigdahl B. Retrovirology. 2: P37. DOI: 10.1186/1742-4690-2-S1-P37  0.718
2005 Flaig K, Jain P, Mostoller K, Wigdahl B. Protein-protein Interaction Between HTLV-1 Tax Protein and the Components of the Cellular Secretory Pathway Retrovirology. 2: 31. DOI: 10.1186/1742-4690-2-S1-P31  0.328
2005 Ferguson ML, Miller S, Labib ME, Rando R, Kholodovych V, Welsh W, Wigdahl B, Krebs FC. Retrovirology. 2: P30. DOI: 10.1186/1742-4690-2-S1-P30  0.466
2005 Datta S, Jain P, Ahuja J, Wigdahl B. Human Antigen Presenting Cell Gene Array Profiling of the Effect of Human T Cell Leukemia Virus Type 1 Tax Protein on Dendritic Cells Retrovirology. 2: 25. DOI: 10.1186/1742-4690-2-S1-P25  0.368
2004 Mostoller K, Norbury CC, Jain P, Wigdahl B. Human T-cell leukemia virus type I Tax induces the expression of dendritic cell markers associated with maturation and activation. Journal of Neurovirology. 10: 358-71. PMID 15765807 DOI: 10.1080/13550280490521104  0.797
2004 Nonnemacher MR, Irish BP, Liu Y, Mauger D, Wigdahl B. Specific sequence configurations of HIV-1 LTR G/C box array result in altered recruitment of Sp isoforms and correlate with disease progression. Journal of Neuroimmunology. 157: 39-47. PMID 15579278 DOI: 10.1016/J.Jneuroim.2004.08.021  0.72
2004 Burdo TH, Nonnemacher M, Irish BP, Choi CH, Krebs FC, Gartner S, Wigdahl B. High-affinity interaction between HIV-1 Vpr and specific sequences that span the C/EBP and adjacent NF-kappaB sites within the HIV-1 LTR correlate with HIV-1-associated dementia. Dna and Cell Biology. 23: 261-9. PMID 15142383 DOI: 10.1089/104454904773819842  0.796
2004 Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B. Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrobial Agents and Chemotherapy. 48: 1837-47. PMID 15105142 DOI: 10.1128/Aac.48.5.1837-1847.2004  0.805
2004 Kensinger RD, Catalone BJ, Krebs FC, Wigdahl B, Schengrund CL. Novel polysulfated galactose-derivatized dendrimers as binding antagonists of human immunodeficiency virus type 1 infection. Antimicrobial Agents and Chemotherapy. 48: 1614-23. PMID 15105112 DOI: 10.1128/Aac.48.5.1614-1623.2004  0.852
2004 Burdo TH, Gartner S, Mauger D, Wigdahl B. Region-specific distribution of human immunodeficiency virus type 1 long terminal repeats containing specific configurations of CCAAT/enhancer-binding protein site II in brains derived from demented and nondemented patients. Journal of Neurovirology. 10: 7-14. PMID 14982733 DOI: 10.1080/13550280490270789  0.665
2003 Kish TM, Ward MG, Welsh PA, Budgeon LR, Wigdahl B, Howett MK. HIV-1 infection in a small animal human vaginal xenograft model. Journal of Acquired Immune Deficiency Syndromes (1999). 34: 454-60. PMID 14657754 DOI: 10.1097/00126334-200312150-00002  0.549
2003 Barmak K, Harhaj EW, Wigdahl B. Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis. Journal of Neurovirology. 9: 522-9. PMID 13129766 DOI: 10.1080/13550280390218689  0.323
2003 Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration. Virology. 308: 1-12. PMID 12706085 DOI: 10.1016/S0042-6822(02)00091-0  0.747
2003 Alefantis T, Barmak K, Harhaj EW, Grant C, Wigdahl B. Characterization of a nuclear export signal within the human T cell leukemia virus type I transactivator protein Tax. The Journal of Biological Chemistry. 278: 21814-22. PMID 12670929 DOI: 10.1074/Jbc.M211576200  0.736
2003 Quiterio S, Grant C, Hogan TH, Krebs FC, Wigdahl B. C/EBP- and Tat-mediated activation of the HIV-1 LTR in CD34+ hematopoietic progenitor cells. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 57: 49-56. PMID 12642037 DOI: 10.1016/S0753-3322(02)00332-3  0.86
2003 Hogan TH, Nonnemacher MR, Krebs FC, Henderson A, Wigdahl B. HIV-1 Vpr binding to HIV-1 LTR C/EBP cis-acting elements and adjacent regions is sequence-specific. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 57: 41-8. PMID 12642036 DOI: 10.1016/S0753-3322(02)00333-5  0.701
2003 Nonnemacher MR, Hogan TH, Quiterio S, Wigdahl B, Henderson A, Krebs FC. Identification of binding sites for members of the CCAAT/enhancer binding protein transcription factor family in the simian immunodeficiency virus long terminal repeat. Biomedicine & Pharmacotherapy = BioméDecine & PharmacothéRapie. 57: 34-40. PMID 12642035 DOI: 10.1016/S0753-3322(02)00334-7  0.849
2003 Hogan TH, Stauff DL, Krebs FC, Gartner S, Quiterio SJ, Wigdahl B. Structural and functional evolution of human immunodeficiency virus type 1 long terminal repeat CCAAT/enhancer binding protein sites and their use as molecular markers for central nervous system disease progression. Journal of Neurovirology. 9: 55-68. PMID 12587069 DOI: 10.1080/13550280390173292  0.853
2002 Hogan TH, Krebs FC, Wigdahl B. Regulation of human immunodeficiency virus type 1 gene expression and pathogenesis by CCAAT/enhancer binding proteins in cells of the monocyte/macrophage lineage. Journal of Neurovirology. 8: 21-6. PMID 12491147 DOI: 10.1080/13550280290167911  0.51
2002 Krebs FC, Miller SR, Catalone BJ, Fichorova R, Anderson D, Malamud D, Howett MK, Wigdahl B. Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate. Antimicrobial Agents and Chemotherapy. 46: 2292-8. PMID 12069993 DOI: 10.1128/Aac.46.7.2292-2298.2002  0.789
2002 Grant C, Barmak K, Alefantis T, Yao J, Jacobson S, Wigdahl B. Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation. Journal of Cellular Physiology. 190: 133-59. PMID 11807819 DOI: 10.1002/Jcp.10053  0.758
2001 Ross HL, Gartner S, McArthur JC, Corboy JR, McAllister JJ, Millhouse S, Wigdahl B. HIV-1 LTR C/EBP binding site sequence configurations preferentially encountered in brain lead to enhanced C/EBP factor binding and increased LTR-specific activity. Journal of Neurovirology. 7: 235-49. PMID 11517398 DOI: 10.1080/13550280152403281  0.783
2001 Ross HL, Nonnemacher MR, Hogan TH, Quiterio SJ, Henderson A, McAllister JJ, Krebs FC, Wigdahl B. Interaction between CCAAT/enhancer binding protein and cyclic AMP response element binding protein 1 regulates human immunodeficiency virus type 1 transcription in cells of the monocyte/macrophage lineage. Journal of Virology. 75: 1842-56. PMID 11160683 DOI: 10.1128/Jvi.75.4.1842-1856.2001  0.798
2000 Krebs FC, Ross H, McAllister J, Wigdahl B. HIV-I-associated central nervous system dysfunction Advances in Pharmacology. 49: 315-385. PMID 11013768 DOI: 10.1016/S1054-3589(00)49031-9  0.798
2000 McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication. Virology. 274: 262-77. PMID 10964770 DOI: 10.1006/Viro.2000.0476  0.8
2000 Krebs FC, Miller SR, Catalone BJ, Welsh PA, Malamud D, Howett MK, Wigdahl B. Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes. Antimicrobial Agents and Chemotherapy. 44: 1954-60. PMID 10858360 DOI: 10.1128/Aac.44.7.1954-1960.2000  0.777
2000 Yao J, Wigdahl B. Human T cell lymphotropic virus type I genomic expression and impact on intracellular signaling pathways during neurodegenerative disease and leukemia Frontiers in Bioscience : a Journal and Virtual Library. 5. PMID 10702386 DOI: 10.2741/Yao  0.469
1999 Krebs FC, Miller SR, Malamud D, Howett MK, Wigdahl B. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate Antiviral Research. 43: 157-173. PMID 10551374 DOI: 10.1016/S0166-3542(99)00044-3  0.428
1998 Millhouse S, Krebs FC, Yao J, McAllister JJ, Conner J, Ross H, Wigdahl B. Sp1 and related factors fail to interact with the NF-kappaB-proximal G/C box in the LTR of a replication competent, brain-derived strain of HIV-1 (YU-2). Journal of Neurovirology. 4: 312-23. PMID 9639074 DOI: 10.3109/13550289809114532  0.767
1998 Krebs FC, Mehrens D, Pomeroy S, Goodenow MM, Wigdahl B. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes Journal of Biomedical Science. 5: 31-44. PMID 9570512 DOI: 10.1007/Bf02253354  0.431
1994 Kenny JJ, Krebs FC, Hartle HT, Gartner AE, Chatton B, Leiden JM, Hoeffler JP, Weber PC, Wigdahl B. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter. Virology. 200: 220-35. PMID 8128624 DOI: 10.1006/Viro.1994.1180  0.386
1994 Tillmann M, Krebs FC, Wessner R, Pomeroy SM, Goodenow MM, Wigdahl B. Neuroglial-specific factors and the regulation of retrovirus transcription Advances in Neuroimmunology. 4: 305-318. PMID 7874399 DOI: 10.1016/S0960-5428(06)80271-8  0.422
1992 Kollas BB, Hartle HT, Wigdahl B. Effect of γ-interferon on the expression of major histocompatibility complex class I and II gene products in neural cells isolated from the developing human fetal peripheral nervous system Fetal Diagnosis and Therapy. 7: 62-74. PMID 1380249 DOI: 10.1159/000263652  0.31
1992 Weber PC, Kenny JJ, Wigdahl B. Antiviral properties of a dominant negative mutant of the herpes simplex virus type 1 regulatory protein ICP0 Journal of General Virology. 73: 2955-2961. PMID 1331297 DOI: 10.1099/0022-1317-73-11-2955  0.376
1992 Weber PC, Wigdahl B. Identification of dominant-negative mutants of the herpes simplex virus type 1 immediate-early protein ICP0 Journal of Virology. 66: 2261-2267. PMID 1312631 DOI: 10.1128/Jvi.66.4.2261-2267.1992  0.345
1991 Kunsch C, Wigdahl B. Maintenance of human immunodeficiency virus type-1 proviral DNA in human fetal dorsal root ganglia neural cells following a nonproductive infection Journal of Leukocyte Biology. 49: 505-510. PMID 2016571  0.473
1991 Tillmann M, Wigdahl B. Neuropathogenesis of human immunodeficiency virus infection Seminars in Neuroscience. 3: 131-139. DOI: 10.1016/1044-5765(91)90008-C  0.462
1990 Kunsch C, Wigdahl B. Analysis of nonproductive human immunodeficiency virus type 1 infection of human fetal dorsal root ganglia glial cells Intervirology. 31: 147-158. PMID 1695619  0.486
1989 Harouse JM, Kunsch C, Hartle HT, Laughlin MA, Hoxie JA, Wigdahl B, Gonzalez-Scarano F. CD4-independent infection of human neural cells by human immunodeficiency virus type 1 Journal of Virology. 63: 2527-2533. PMID 2786088 DOI: 10.1128/Jvi.63.6.2527-2533.1989  0.383
1989 Wigdahl B, Kunsch C. Role of HIV in human nervous system dysfunction Aids Research and Human Retroviruses. 5: 369-374. PMID 2669896  0.397
1989 Kunsch C, Wigdahl B. Transient expression of human immunodeficiency virus type 1 genome results in a nonproductive infection in human fetal dorsal root ganglia glial cells Virology. 173: 715-722. PMID 2512746 DOI: 10.1016/0042-6822(89)90585-0  0.472
1989 Kunsch C, Hartle HT, Wigdahl B. Infection of human fetal dorsal root ganglion glial cells with human immunodeficiency virus type 1 involves an entry mechanism independent of the CD4 T4A epitope Journal of Virology. 63: 5054-5061. PMID 2479771  0.387
1987 Wigdahl B, Guyton RA, Sarin PS. Human immunodeficiency virus infection of the developing human nervous system Virology. 159: 440-445. PMID 3650007 DOI: 10.1016/0042-6822(87)90483-1  0.442
Low-probability matches (unlikely to be authored by this person)
1982 Wigdahl BL, Scheck AC, De Clercq E, Rapp F. High efficiency latency and activation of herpes simplex virus in human cells Science. 217: 1145-1146. PMID 6180477 DOI: 10.1126/Science.6180477  0.286
1990 Kolias BB, Hartle HT, Wigdahl B. Analysis of major histocompatibility complex gene products in tissues isolated from the developing human nervous system Fetal Diagnosis and Therapy. 5: 124-137. PMID 1718314 DOI: 10.1159/000263581  0.284
1984 Hung T, Mummaw JG, Wigdahl BL, Fang ZY, Huayinga J, Rapp F. Ultrastructural changes during herpes simplex virus type 2 latency and reactivation in vitro Intervirology. 21: 5-16. PMID 6698759 DOI: 10.1159/000149498  0.275
2007 Manuel SL, Rahman S, Wigdahl B, Khan ZK, Jain P. Dendritic cells in autoimmune diseases and neuroinflammatory disorders. Frontiers in Bioscience : a Journal and Virtual Library. 12: 4315-35. PMID 17485377 DOI: 10.2741/2390  0.274
2009 Lepoutre V, Jain P, Quann K, Wigdahl B, Khan ZK. Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease. Frontiers in Bioscience (Landmark Edition). 14: 1152-68. PMID 19273122 DOI: 10.2741/3300  0.272
1987 Scheck AC, Wigdahl B, Rapp F. Activation of latent herpes simplex virus type 2 infection in vitro requires a (E)-5-(2-bromovinyl)-2′-deoxyuridine-sensitive gene function Intervirology. 27: 121-129. PMID 2822602 DOI: 10.1159/000149730  0.27
1997 Wessner R, Yao J, Wigdahl B. Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer Leukemia. 11: 10-13. PMID 9209281  0.27
1983 Bucher LJ, Wigdahl B, Rapp F. Maintenance of human cytomegalovirus genome in human diploid fibroblast cells. Virology. 130: 269-71. PMID 6314650 DOI: 10.1016/0042-6822(83)90139-3  0.267
1994 Tillmann M, Wessner R, Wigdahl B. Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes Journal of Virology. 68: 4597-4608. PMID 8207834  0.267
2022 Grethlein D, Pirrone V, Devlin KN, Dampier W, Szep Z, Winston FK, Ontañón S, Walshe EA, Malone K, Tillman S, Ances BM, Kandadai V, Kolson DL, Wigdahl B. Examining virtual driving test performance and its relationship to individuals with HIV-associated neurocognitive disorders. Frontiers in Neuroscience. 16: 912766. PMID 36090285 DOI: 10.3389/fnins.2022.912766  0.267
2023 Sutter J, Bruggeman PJ, Wigdahl B, Krebs FC, Miller V. Manipulation of Oxidative Stress Responses by Non-Thermal Plasma to Treat Herpes Simplex Virus Type 1 Infection and Disease. International Journal of Molecular Sciences. 24. PMID 36902102 DOI: 10.3390/ijms24054673  0.258
1990 Wigdahl B, Kunsch C. Human immunodeficiency virus infection and neurologic dysfunction Progress in Medical Virology. Fortschritte Der Medizinischen Virusforschung. Progres En Virologie Medicale. 37: 1-46. PMID 2244008  0.255
1986 Scheck AC, Wigdahl B, De Clercq E, Rapp F. Prolonged herpes simplex virus latency in vitro after treatment of infected cells with acyclovir and human leukocyte interferon Antimicrobial Agents and Chemotherapy. 29: 589-593. PMID 3010847 DOI: 10.1128/Aac.29.4.589  0.249
2006 Rando RF, Obara S, Osterling MC, Mankowski M, Miller SR, Ferguson ML, Krebs FC, Wigdahl B, Labib M, Kokubo H. Critical design features of phenyl carboxylate-containing polymer microbicides. Antimicrobial Agents and Chemotherapy. 50: 3081-9. PMID 16940105 DOI: 10.1128/Aac.01609-05  0.247
1981 Wigdahl BL, Isom HC, Rapp F. Repression and activation of the genome of herpes simplex viruses in human cells Proceedings of the National Academy of Sciences of the United States of America. 78: 6522-6526. PMID 6273875 DOI: 10.1073/Pnas.78.10.6522  0.245
1997 Kenny JJ, Millhouse S, Wotring M, Wigdahl B. Upstream stimulatory factor family binds to the herpes simplex virus type 1 latency-associated transcript promoter Virology. 230: 381-391. PMID 9143295 DOI: 10.1006/viro.1997.8501  0.245
1982 Hung T, Fang ZY, Wigdahl B, Rapp F. ULTRASTRUCTURAL CHANGES IN HUMAN CELLS ASSOCIATED WITH HERPES VIRUS LATENCY AND REACTIVATION IN VITRO Proceedings - Electron Microscopy Society of America. 308-309.  0.24
1995 Wessner R, Tillmann-Bogush M, Wigdahl B. Characterization of a glial cell-specific DNA-protein complex formed with the human T cell lymphotropic virus type I (HTLV-I) enhancer Journal of Neurovirology. 1: 62-77. PMID 9222343  0.238
2000 Millhouse S, Wigdahl B. Molecular circuitry regulating herpes simplex virus type 1 latency in neurons Journal of Neurovirology. 6: 6-24. PMID 10786993  0.237
1989 Scheck AC, Wigdahl B, Rapp F. Transcriptional activity of the herpes simplex virus genome during establishment, maintenance, and reactivation of in vitro virus latency Intervirology. 30: 121-136. PMID 2473963 DOI: 10.1159/000150084  0.237
2012 Lozenski K, Kish-Catalone T, Wigdahl B, Krebs F. In Vitro and In Vivo Measures of Microbicide Safety Differ Considerably in a Multiple Exposure Study Gender Medicine. 9: S94. DOI: 10.1016/J.Genm.2011.09.005  0.235
1997 Krebs FC, Goodenow MM, Wigdahl B. Neuroglial ATF/CREB factors interact with the human immunodeficiency virus type 1 long terminal repeat Journal of Neurovirology. 3. PMID 9179787  0.231
1998 Mulhouse S, Kenny JJ, Quinn PG, Lee V, Wigdahl B. ATF/CREB elements in the herpes simplex virus type 1 latency-associated transcript promoter interact with members of the ATF/CREB and AP-1 transcription factor families Journal of Biomedical Science. 5: 451-464. PMID 9845850  0.229
1982 Wigdahl BL, Isom HC, De Clercq E, Rapp F. Activation of herpes simplex virus (HSV) type 1 genome by temperature-sensitive mutants of HSV type 2. Virology. 116: 468-79. PMID 6278723 DOI: 10.1016/0042-6822(82)90140-4  0.228
2021 Mohamed H, Gebski E, Reyes R, Beane S, Wigdahl B, Krebs FC, Stapelmann K, Miller V. Differential Effect of Non-Thermal Plasma RONS on Two Human Leukemic Cell Populations. Cancers. 13. PMID 34069922 DOI: 10.3390/cancers13102437  0.224
1984 Wigdahl B, Scheck AC, Ziegler RJ, De Clercq E, Rapp F. Analysis of the herpes simplex virus genome during in vitro latency in human diploid fibroblasts and rat sensory neurons Journal of Virology. 49: 205-213. PMID 6317890 DOI: 10.1128/Jvi.49.1.205-213.1984  0.221
2009 Lozenski K, Kish-Catalone T, Wigdahl B, Krebs F. Nonoxynol-9 (N-9), After Repeated Applications, Does not Result in Cumulative Damage to the Murine Cervicovaginal Epithelium Antiviral Research. 82: A64-A65. DOI: 10.1016/J.Antiviral.2009.02.156  0.219
1978 Wigdahl BL, Parkhurst JR. HEp-2 cell- and herpes simplex virus type 1- induced deoxythymidine kinases: Inhibition by derivatives of 5-trifluoromethyl-2'-deoxyuridine Antimicrobial Agents and Chemotherapy. 14: 470-475. PMID 213016  0.214
1994 Tillmann M, Wigdahl B. Identification of HTLV-I 21 bp repeat-specific DNA-protein complexes Leukemia. 8. PMID 8152311  0.212
2020 Mohamed H, Esposito RA, Kutzler MA, Wigdahl B, Krebs FC, Miller V. Nonthermal plasma as part of a novel strategy for vaccination. Plasma Processes and Polymers (Print). e2000051. PMID 32837491 DOI: 10.1002/Ppap.202000051  0.21
2012 Passic S, Wigdahl B, Doncel G, Krebs F. Using the Conrad Microbicide Testing Algorithm to Screen Single Compounds and Agent Combinations for Cytotoxicity and Anti–HIV-1 Activity Gender Medicine. 9: S94-S95. DOI: 10.1016/J.Genm.2011.09.006  0.206
1981 Wigdahl BL, Parkhurst JR. Inhibition of mouse LM cell replication by trifluorothymidine: Role of cytosolic deoxythymidine kinase Antimicrobial Agents and Chemotherapy. 19: 881-890. PMID 6271050  0.203
1983 Wigdahl BL, Ziegler RJ, Sneve M, Rapp F. Herpes simplex virus latency and reactivation in isolated rat sensory neurons. Virology. 127: 159-67. PMID 6305013 DOI: 10.1016/0042-6822(83)90380-X  0.199
2023 Haslund-Gourley B, Woloszcuk K, Hou J, Connors J, Cusimano G, Bell M, Taramangalam B, Fourati S, Mege N, Bernui M, Altman M, Krammer F, van Bakel H, Maecker H, Wigdahl B, et al. IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition. Research Square. PMID 37398192 DOI: 10.21203/rs.3.rs-2939468/v1  0.192
1984 Wigdahl B, Smith CA, Traglia HM, Rapp F. Herpes simplex virus latency in isolated human neurons Proceedings of the National Academy of Sciences of the United States of America. 81: 6217-6221. PMID 6091142 DOI: 10.1073/Pnas.81.19.6217  0.189
2018 Brown CL, Comunale MA, Wigdahl B, Urdaneta-Hartmann S. Current Climate for Digital Game-Based Learning of Science in Further and Higher Education. Fems Microbiology Letters. PMID 30260380 DOI: 10.1093/Femsle/Fny237  0.187
1999 Howett MK, Neely EB, Christensen ND, Wigdahl B, Krebs FC, Malamud D, Patrick SD, Pickel MD, Welsh PA, Reed CA, Ward MG, Budgeon LR, Kreider JW. A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses. Antimicrobial Agents and Chemotherapy. 43: 314-21. PMID 9925525 DOI: 10.1128/Aac.43.2.314  0.185
2024 Haslund-Gourley BS, Woloszczuk K, Hou J, Connors J, Cusimano G, Bell M, Taramangalam B, Fourati S, Mege N, Bernui M, Altman MC, Krammer F, van Bakel H, Maecker HT, Rouphael N, ... ... Wigdahl B, et al. IgM N-glycosylation correlates with COVID-19 severity and rate of complement deposition. Nature Communications. 15: 404. PMID 38195739 DOI: 10.1038/s41467-023-44211-0  0.178
2003 Wang G, Christensen ND, Wigdahl B, Guttentag SH, Floros J. Differences in N-linked glycosylation between human surfactant protein-B variants of the C or T allele at the single-nucleotide polymorphism at position 1580: implications for disease. The Biochemical Journal. 369: 179-84. PMID 12356334 DOI: 10.1042/Bj20021376  0.173
1986 Wigdahl B, Rong BL, Kinney-Thomas E. Varicella-zoster virus infection of human sensory neurons. Virology. 152: 384-99. PMID 2425480 DOI: 10.1016/0042-6822(86)90141-8  0.166
1990 Carrat F, Ringa V, Blondel B, Bréart G, Kollas BB, Hartle HT, Wigdahl B, Thorpe-Beeston G, Nicolaides KH, Snijders RJM, Felton CV, Leduc L, Moise KJ, Carpenter RJ, Cano LE, et al. Contents, Vol. 5, 1990 Fetal Diagnosis and Therapy. 5. DOI: 10.1159/000263578  0.157
2022 Haslund-Gourley BS, Grauzam S, Mehta AS, Wigdahl B, Comunale MA. Acute lyme disease IgG N-linked glycans contrast the canonical inflammatory signature. Frontiers in Immunology. 13: 949118. PMID 35990620 DOI: 10.3389/fimmu.2022.949118  0.155
2024 Haslund-Gourley BS, Hou J, Woloszczuk K, Horn EJ, Dempsey G, Haddad EK, Wigdahl B, Comunale MA. Host glycosylation of immunoglobulins impairs the immune response to acute Lyme disease. Ebiomedicine. 100: 104979. PMID 38266555 DOI: 10.1016/j.ebiom.2024.104979  0.143
2023 Haslund-Gourley BS, Wigdahl B, Comunale MA. IgG N-glycan Signatures as Potential Diagnostic and Prognostic Biomarkers. Diagnostics (Basel, Switzerland). 13. PMID 36980324 DOI: 10.3390/diagnostics13061016  0.131
1983 Smith CA, Wigdahl B, Rapp F. Synergistic antiviral activity of acyclovir and interferon on human cytomegalovirus Antimicrobial Agents and Chemotherapy. 24: 325-332. PMID 6314891 DOI: 10.1128/AAC.24.3.325  0.108
1984 Isom HC, Gao M, Wigdahl B. Characterization of guinea pig cytomegalovirus DNA Journal of Virology. 49: 426-436. PMID 6319742 DOI: 10.1128/Jvi.49.2.426-436.1984  0.108
2008 Pavlovic J, Floros J, Phelps DS, Wigdahl B, Welsh P, Weisz J, Shearer DA, Leure du Pree A, Myers R, Howett MK. Differentiation of xenografted human fetal lung parenchyma. Early Human Development. 84: 181-93. PMID 17555893 DOI: 10.1016/J.Earlhumdev.2007.04.002  0.101
1996 Wigdahl B, Brady JN. Molecular aspects of HTLV-I: Relationship to neurological diseases Journal of Neurovirology. 2: 307-322. PMID 8912207  0.077
1978 Clough DW, Wigdahl BL, Parkhurst JR. Biological effects of 5 carboxy 2' deoxyuridine: hydrolysis product of 5 trifluoromethyl 2' deoxyuridine Antimicrobial Agents and Chemotherapy. 14: 126-131. PMID 28691  0.048
2006 Krebs F, Kish-Catalone T, Wigdahl B. Editorial comment: Providing expanded support for microbicide research Aids Reader. 16: 156-157.  0.028
Hide low-probability matches.